Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086.
- 2014-12
- Anaerobe 30
- Edna P Nyangale
- S. Farmer
- D. Keller
- D. Chernoff
- G. Gibson
- PubMed: 25219857
- DOI: 10.1016/j.anaerobe.2014.09.002
Abstract
In advancing age, gut populations of beneficial microbes, notably Bifidobacterium spp., show a marked decline. This contributes to an environment less capable of maintaining homoeostasis. This in vitro investigation studied the possible synergistic effects of probiotic supplementation in modulating the gut microbiota enabling prebiotic therapy to in elderly persons. Single stage batch culture anaerobic fermenters were used and inoculated with fecal microbiota obtained from volunteers after taking a 28 day treatment of Bacillus coagulans GBI-30, 6086 (GanedenBC30 (BC30)) or a placebo. The response to prebiotic supplements fructooligosaccharides (FOS) and galactooligosaccharides (GOS) in the fermenters was assessed. Bacterial enumeration was carried out using fluorescent in situ hybridisation and organic acids measured by gas chromatography. Baseline populations of Faecalibacterium prausnitzii, Clostridium lituseburense and Bacillus spp. were significantly higher in those having consumed BC30 compared to the placebo. Both prebiotics increased populations of several purportedly beneficial bacterial groups in both sets of volunteers. Samples from volunteers having ingested the BC30 also increased populations of C. lituseburense, Eubacterium rectale and F. prausnitzii more so than in persons who had consumed the placebo, this also resulted in significantly higher concentrations of butyrate, acetate and propionate. This shows that consumption of BC30 and subsequent use of prebiotics resulted in elevated populations of beneficial genres of bacteria as well as organic acid production.
Keywords: Bacillus coagulans; Batch culture fermentation; Fructooligosaccharides; Galactooligosaccharides; Probiotic; Synbiotic.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bacillus coagulans GBI-30, 6086 | Improved Response to Prebiotics | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Increased Bifidobacterial Population | Beneficial | Large |
Bacillus coagulans ProDura | Improved Response to Prebiotics | Beneficial | Moderate |
Bacillus coagulans ProDura | Increased Beneficial Organic Acid Levels | Beneficial | Large |
Bacillus coagulans ProDura | Increased Bifidobacterial Population | Beneficial | Large |
Bacillus coagulans SC208 | Increased Beneficial Bacteria Populations | Beneficial | Moderate |
Bacillus coagulans SNZ-1969 | Increased Bifidobacterial Population | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Increased Bifidobacterial Population | Beneficial | Large |